glp-1 agonists and inflammation Potential Use of GIP/GLP-1 Receptor for Respiratory Disorders: Where Are We at? Can one drug do it
Description
When given in higher doses, however, nausea became more pronounced
Previous research has found that people on GLP-1 medications are less likely to develop dementia in some cases
Exenatide became the first FDA-approved GLP-1 analog in 2005
Nat Chem Biol 5(10):749757
Shima Hadidchi MD Family Practice, we focus on providing the best options for weight management
